16.72

1.09% 0.18

Castle Biosciences Inc (CSTL)

Overview News Price History Option Chain Financials Why CSTL Down? Discussions Forecast

Castle Biosciences Inc stock is traded at $16.72, with a volume of 543.37K. It is up +1.09% in the last 24 hours and down -9.72% over the past month. Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

Previous Close:

$16.54

Open:

$16.54

24h Volume:

543.37K

Relative Volume:

1.18

Market Cap:

$482.75M

Revenue:

$219.79M

Net Income/Loss:

$-57.47M

P/E Ratio:

-7.7767

EPS:

-2.15

Net Cash Flow:

$-19.25M

1W Performance:

-14.26%

1M Performance:

-9.72%

6M Performance:

-37.43%

1Y Performance:

-16.06%

1-Day Range:

$16.25

$16.95

1-Week Range:

$16.25

$19.70

52-Week Range:

$15.45

$35.84

Castle Biosciences Inc Stock (CSTL) Company Profile

Name

Castle Biosciences Inc

Sector

Healthcare (1161)

Industry

Diagnostics & Research (54)

Phone

866-788-9007

Address

505 S FRIENDSWOOD DRIVE, FRIENDSWOOD, TX

Employee

784

Twitter

@castlebio

Next Earnings Date

2024-11-04

Latest SEC Filings

CSTL's Discussions on Twitter

Compare CSTL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CSTL Castle Biosciences Inc	16.72	563.01M	219.79M	-57.47M	-19.25M	-2.15
TMO Thermo Fisher Scientific Inc	404.94	160.56B	42.90B	6.52B	6.72B	17.05
DHR Danaher Corp	188.07	141.52B	23.82B	3.77B	4.90B	5.15
IDXX Idexx Laboratories Inc	520.87	42.74B	3.93B	894.97M	837.70M	10.82
A Agilent Technologies Inc	112.04	34.11B	6.63B	1.17B	1.19B	4.05
IQV Iqvia Holdings Inc	158.96	27.70B	15.50B	1.33B	2.16B	7.34

Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-14-23	Initiated	Guggenheim	Buy
Jan-05-23	Initiated	Scotiabank	Sector Outperform
Jan-07-22	Initiated	Stephens	Overweight
Apr-30-21	Initiated	Lake Street	Buy
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight
Dec-27-19	Reiterated	Canaccord Genuity	Buy
Aug-19-19	Initiated	BTIG Research	Buy
Aug-19-19	Initiated	Canaccord Genuity	Buy
Aug-19-19	Initiated	Robert W. Baird	Outperform
Aug-19-19	Initiated	SVB Leerink	Outperform

View All

Castle Biosciences Inc Stock (CSTL) Latest News

Jul 21, 2025

Teacher Retirement System of Texas Grows Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jul 21, 2025

Stephens Inc. AR Has $273,000 Stake in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jul 21, 2025

Jul 20, 2025

Castle Biosciences Inc. Stock Analysis and ForecastBreakneck growth rates - jammulinksnews.com

Jul 20, 2025

What drives Castle Biosciences Inc. stock priceFree Trading Strategy Suggestions - jammulinksnews.com

Jul 20, 2025

What analysts say about Castle Biosciences Inc. stockFree Investment Case Studies - PrintWeekIndia

Jul 20, 2025

Jul 18, 2025

Is Castle Biosciences Inc. a good long term investmentHigh-yield trading alerts - Jammu Links News

Jul 18, 2025

Jul 17, 2025

Castle Biosciences Achieves Multiple Awards Recognizing Workplace Excellence in 2025 Top Workplaces Program - Quiver Quantitative

Jul 17, 2025

Castle Biosciences earns multiple Top Workplaces awards, including national Healthcare Industry award. - AInvest

Jul 17, 2025

Castle Biosciences Honored with Multiple Top Workplaces Awards Recognizing the Company’s Strong Culture - GlobeNewswire

Jul 17, 2025

Castle Biosciences Dominates Healthcare Workplace Rankings with 7 Major Awards and #3 Industry Position - Stock Titan

Jul 17, 2025

Jul 16, 2025

How Castle Biosciences Inc. stock performs during market volatilityTop Rated Trade Entries - Newser

Jul 16, 2025

Castle Biosciences, Inc. (NASDAQ:CSTL) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Jul 16, 2025

Castle Biosciences to Release Q2 2025 Financial Results and Host Conference Call on Aug. 4 - AInvest

Jul 16, 2025

Jul 15, 2025

Why Castle Biosciences Inc. stock attracts strong analyst attentionEarly Buy Suggestion - Newser

Jul 15, 2025

What makes Castle Biosciences Inc. stock price move sharplyProven Trading Plan - Newser

Jul 15, 2025

Jul 14, 2025

Castle Biosciences' Q2 Results: Diagnostic Innovation Fuels Growth Amid Profit Challenges - AInvest

Jul 14, 2025

Castle Biosciences, Inc. to Release Second Quarter Financial Results on August 4, 2025 - Nasdaq

Jul 14, 2025

Castle Biosciences to Release Second Quarter 2025 Financial - GlobeNewswire

Jul 14, 2025

Castle Biosciences Sets Q2 2025 Earnings Date: Key Financial Results Coming August 4 - Stock Titan

Jul 14, 2025

Jul 07, 2025

Allspring Global Investments Holdings LLC Raises Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jul 07, 2025

Jun 30, 2025

Castle Biosciences, Inc.(NasdaqGM: CSTL) dropped from Russell 2500 Growth Index - MarketScreener

Jun 30, 2025

Jun 28, 2025

Is Castle Biosciences (NASDAQ:CSTL) Using Too Much Debt? - 富途牛牛

Jun 28, 2025

Jun 25, 2025

GAMMA Investing LLC Purchases 4,142 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jun 25, 2025

Castle Biosciences partners with SciBase for diagnostic tests - MSN

Jun 25, 2025

Jun 19, 2025

Castle Biosciences Awards Major RSU Package: 135,978 Shares with 4-Year Vesting for Employee Retention - Stock Titan

Jun 19, 2025

Jun 17, 2025